相关实验视频
Updated: Jul 18, 2026

05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
制药行业作为一个政治参与者
1Centre for Research in Health and Medicine, University of Sussex, BN1 9SN, Brighton, UK. j.w.abraham@sussex.ac.uk
Lancet (London, England)
|November 16, 2002
概括
制药行业的监管必须平衡利益与公共卫生保护. 这项研究考察了行业对药物监管的影响,并提出了加强对更安全药物的监管的方法.
科学领域:
- 制药政策 制药政策
- 监管科学是一种监管科学.
- 公共卫生 公共卫生
背景情况:
- 制药行业提供基本药物,需要治理的政治框架.
- 强有力的监管对于保护公众健康免受不安全,无效或不必要的药物至关重要.
- 目前的药物监管系统可能会受到行业影响的影响,可能不利于公共利益.
研究的目的:
- 分析制药行业对药物监管过程的影响程度.
- 确定行业影响政府和监管机构的机制.
- 提出减轻行业过度影响和加强监管稳健性的战略.
主要方法:
- 讨论制药行业用来影响监管机构的各种方法.
- 分析政治和经济因素,使工业影响.
- 审查现有的监管框架及其漏洞.
主要成果:
- 制药行业通过各种道对药物监管产生重大影响.
- 这种影响可能会损害监管监督的客观性和有效性.
- 现有的监管系统可能无法充分保护公众健康免受行业压力.
结论:
- 加强管理制药行业的政治框架至关重要.
- 实施制行业影响的措施是强有力的药物监管所必需的.
- 加强监督至关重要,以确保药品的安全性,有效性和公共利益的必要性.
相关概念视频
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.

